مساحة عمل الرمز اللحظية

ذكاء سوق XLV

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

الحالي $146.81

الاتجاه ثبات

المشاعر Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

تحليل السوق المفصل

المستويات الرئيسية

الدعم

$139.47

المقاومة

$154.15

الحجم & الزخم

الحجم

ضعيف

0,8x المتوسط

الزخم

0%

Weak

Technical Context

Current price

$146.81

RSI context

50

معنويات السوق

50

Neutral

سهم المقاييس

الحجم اليومي

0%

تقدير VIX

20

أسبوعي

0%

ملف ذكاء الأصل

Over the last 30 days, AI sentiment for XLV skewed bullish (7 of 14 scored calls).

سجل أداء المزوّد

لا توجد بعد استدعاءات مزوّدين مُقيَّمة كافية لهذا الأصل.

اتجاه الثقة

30%

▼ 8,8 نقطة مقارنة بالأسبوع السابق

متوسط الثقة عبر 26 استدعاءً خلال آخر 7 أيام

ماذا تقول المصادر

صاعد 7 مقالات

3 Healthcare Stocks with Open Questions

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

محايد 5 مقالات

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

هابط 2 مقالان

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

تداول المطلعين

جارٍ تحديث صفقات المطّلعين من FinViz…

Technical Observations

Refreshing technical observations from FinViz...

أخبار XLV الذكية (32 مقالات)

أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر XLV والمشاعر والاتجاه

استكشف جميع أخبار XLV مع تحليل الذكاء الاصطناعي

Economy

1 أسبوع، 1 يوم منذ

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited …

التأثير على XLV: The healthcare sector's outperformance is likely to attract investor attention, potentially leading …

The healthcare sector has outperformed the S&P 500 by 11.2 percentage points over the past … الأعلى (70%)

عرض التحليل الكامل →

Yahoo Finance 70% الثقة

Economy

1 أسبوع، 5 أيام منذ

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

XLV's concentrated 60-stock portfolio beat VHT's broader 423 holdings over five years, though VHT delivered stronger 1-year returns.

التأثير على XLV: يُتوقع حركة سعرية إيجابية محتملة

Analysis of stock market developments showing bullish sentiment. متوسط (60%)

عرض التحليل الكامل →

Yahoo Finance 60% الثقة

Economy

2 أسبوعين، 1 يوم منذ

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

XLV's lower costs and broader holdings delivered 30% more growth over five years, while BBH's concentrated biotech focus offers higher …

التأثير على XLV: يُتوقع حركة سعرية إيجابية محتملة

Analysis of stock market developments showing bullish sentiment. متوسط (60%)

عرض التحليل الكامل →

Yahoo Finance 60% الثقة

Economy

2 أسبوعين، 3 أيام منذ

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XBI surged 76% in one year but carries triple the expense ratio and far steeper downside risk. Which fund matches …

التأثير على XLV: تشير المعنويات إلى حياد السوق

Financial market analysis indicating neutral sentiment based on current trends. متوسط (50%)

عرض التحليل الكامل →

Yahoo Finance 50% الثقة

Economy

2 أسبوعين، 5 أيام منذ

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

IBBQ posted the stronger return over the past year, but has also experienced much higher historical volatility than XLV.

التأثير على XLV: The outperformance of IBBQ may attract investors seeking growth, potentially leading to …

The IBBQ biotech ETF has outperformed XLV over the past year but with higher volatility, … متوسط (60%)

عرض التحليل الكامل →

Yahoo Finance 60% الثقة

Economy

2 أسبوعين، 5 أيام منذ

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

PBE surged 41% in one year but endured a 35% drawdown, while XLV's diversified approach delivered steadier gains with half …

التأثير على XLV: The comparison between XLV and PBE may lead to capital rotation from …

The healthcare ETF XLV has demonstrated steadier gains and lower volatility compared to the biotech … الأعلى (70%)

عرض التحليل الكامل →

Yahoo Finance 70% الثقة